QA/RA teams are under pressure to use AI, but validating non-deterministic tools is unclear. This session provides a risk-based framework to define scope, generate audit-ready evidence, and maintain compliance w/o delay.
Quality and regulatory teams are under increasing pressure to use AI to scale their impact and support faster, AI-assisted development. As non-product software is used in regulated environments, the tools must be appropriately controlled and validated.
The problem is that most validation approaches were designed for deterministic software. Teams are left unsure what actually needs to be validated, how to evaluate non-deterministic outputs, and what evidence will hold up in an audit. The result is manual reviews, screenshots, and gaps in evidence. This session gives QA/RA professionals a structured, risk-based framework for validating AI tools used within their organization, so you can maintain control and inspection readiness without slowing your team down.
Intermediate: Content is designed based upon the assumption that individuals have basic knowledge of the topic(s) and/or demonstrated competence related to the topic(s). Higher-level concepts are introduced during lectures; exercises requiring synthesis and/or application of concepts are incorporated into the activity.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].


Director of AI Quality & Regulatory Strategy, Ketryx
Jenn Dixon leads quality and regulatory client engagements at Ketryx, where she provides coaching and support for clients wishing to adopt the best software medical device practices. Dixon brings extensive expertise in quality assurance, regulatory affairs, and project management from previous roles in the MedTech industry with a proven ability to develop and apply best practices that optimize both teams and processes.
Prior to Ketryx, she was director of QA/RA at Omniscient Neurotechnology, overseeing global regulatory submissions, maintaining ISO 13485 compliance, and managing cross-functional teams in areas such as post-market surveillance and Good Machine Learning Practices (GMLP). She also served as a design assurance specialist and technical project manager, where she excelled in risk management, audit readiness, and leading agile development teams to deliver innovative solutions.
Dixon began her career at Synaptive Medical, supporting ISO 13485 compliance transitions and leading UDI implementation. She holds a bachelor’s degree in engineering from the University of Toronto.
We have completed our migration to a new platform and are pleased to introduce the updated site.
What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.
We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.
We welcome your feedback. Please let us know how we can continue to improve your experience.